Early-life exposure to gestational diabetes mellitus predisposes offspring to pediatric nonalcoholic fatty liver disease

Copyright © 2024 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights reserved..

Nonalcoholic fatty liver disease (NAFLD) has emerged as the prevailing chronic liver disease in the pediatric population due to the global obesity pandemic. Evidence shows that prenatal and postnatal exposure to maternal abnormalities leads to a higher risk of pediatric NAFLD through persistent alterations in developmental programming. Gestational diabetes mellitus (GDM) is a hyperglycemic syndrome which has become the most prevalent complication in pregnant women. An increasing number of both epidemiologic investigations and animal model studies have validated adverse and long-term outcomes in offspring following GDM exposure in utero. Similarly, GDM is considered a crucial risk factor for pediatric NAFLD. This review aimed to summarize currently published studies concerning the inductive roles of GDM in offspring NAFLD development during childhood and adolescence. Dysregulations in hepatic lipid metabolism and gut microbiota in offspring, as well as dysfunctions in the placenta are potential factors in the pathogenesis of GDM-associated pediatric NAFLD. In addition, potentially effective interventions for GDM-associated offspring NAFLD are also discussed in this review. However, most of these therapeutic approaches still require further clinical research for validation.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - year:2023

Enthalten in:

Hepatobiliary & pancreatic diseases international : HBPD INT - (2023) vom: 30. Dez.

Sprache:

Englisch

Beteiligte Personen:

Zhang, Qian-Ren [VerfasserIn]
Dong, Yan [VerfasserIn]
Fan, Jian-Gao [VerfasserIn]

Links:

Volltext

Themen:

Fetal development
Gestational diabetes mellitus
Journal Article
Lipid metabolism
Nonalcoholic fatty liver disease
Nutrition therapy
Review

Anmerkungen:

Date Revised 09.01.2024

published: Print-Electronic

Citation Status Publisher

doi:

10.1016/j.hbpd.2023.12.007

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM36685948X